Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Epithelial Cancer Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01334047
What this trial is testing

Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

Who this might be right for
Recurrent Epithelial Ovarian Cancer
Steinar Aamdal 5
Testing effectiveness (Phase 2)Ended earlyNCT00004221
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer

Who this might be right for
Malignant Ovarian Mixed Epithelial TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid Adenocarcinoma+5 more
Gynecologic Oncology Group 12
Not applicableStudy completedNCT01080521
What this trial is testing

Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy

Who this might be right for
Cognitive Side Effects of Cancer TherapyMalignant Ovarian Epithelial TumorOvarian Brenner Tumor+51 more
Gynecologic Oncology Group 247
Testing effectiveness (Phase 2)Study completedNCT00317772
What this trial is testing

Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Ovarian CancerPeritoneal NeoplasmsFallopian Tube Cancer
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT02489903
What this trial is testing

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Who this might be right for
Small Cell CarcinomaCarcinoma, Non-Small-Cell LungNeuroendocrine Tumors+1 more
EpicentRx, Inc. 139
Testing effectiveness (Phase 2)Study completedNCT03026062
What this trial is testing

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00928642
What this trial is testing

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cancer
Henry M. Jackson Foundation for the Advancement of Military Medicine 8
Not applicableStudy completedNCT00005956
What this trial is testing

Biological Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerGastric CancerOvarian Cancer
Duke University 3
Testing effectiveness (Phase 2)Ended earlyNCT02900560
What this trial is testing

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Translational Research in Oncology 34
Testing effectiveness (Phase 2)Ended earlyNCT02107378
What this trial is testing

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Who this might be right for
Epithelial Ovarian Carcinoma
SOTIO a.s. 22
Testing effectiveness (Phase 2)Study completedNCT01246440
What this trial is testing

Catumaxomab as a Consolidation Therapy in Patients With Ovarian Cancer in Second or Third Clinical Disease Remission

Who this might be right for
Ovarian Cancer
Grupo Español de Investigación en Cáncer de Ovario 39
Very early researchLooking for participantsNCT07144826
What this trial is testing

Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy

Who this might be right for
Advanced Ovarian CarcinomaRecurrent Ovarian CarcinomaStage II Ovarian Cancer AJCC v8+2 more
Ohio State University Comprehensive Cancer Center 161
Testing effectiveness (Phase 2)Study completedNCT00321633
What this trial is testing

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
University College London Hospitals 148
Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01716715
What this trial is testing

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 111
Testing effectiveness (Phase 2)Ended earlyNCT00550654
What this trial is testing

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

Who this might be right for
Kidney CancerMelanoma (Skin)Metastatic Cancer+3 more
National Institutes of Health Clinical Center (CC) 1
Testing effectiveness (Phase 2)Ended earlyNCT02669914
What this trial is testing

MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors

Who this might be right for
Non-Small Cell Lung CancerNonsmall Cell Lung CancerBreast Cancer+15 more
Washington University School of Medicine 4
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03562897
What this trial is testing

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

Who this might be right for
CarcinomaOvarian NeoplasmEndocrine Gland Neoplasm+10 more
Catalysis SL 40
Early research (Phase 1)UnknownNCT00527631
What this trial is testing

Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Heidelberg University 8
Next Page